Surgical ablation of lingual tonsils in the treatment of obstructive sleep apnea.
Lingual tonsils
Retrolingual space
Sleep apnea
Surgery
Journal
European annals of otorhinolaryngology, head and neck diseases
ISSN: 1879-730X
Titre abrégé: Eur Ann Otorhinolaryngol Head Neck Dis
Pays: France
ID NLM: 101531465
Informations de publication
Date de publication:
Feb 2019
Feb 2019
Historique:
pubmed:
7
12
2018
medline:
31
7
2019
entrez:
4
12
2018
Statut:
ppublish
Résumé
The retrolingual space is one of the potential sites of obstruction identified in patients with obstructive sleep apnea syndrome (OSAS). Hypertrophied lingual tonsils (LT) can obstruct the airway at this level. The goal of this study was to measure the tolerance and efficacy of lingual tonsillectomy in patients with OSAS. A retrospective chart review was conducted recruiting all patients with OSAS confirmed on sleep recording, who either had failed or refused medical treatment and who underwent lingual tonsillectomy. Diagnosis of LT hypertrophy was made by full ENT clinical examination using a flexible endoscopy, completed by MRI and followed by drug-induced sleep endoscopy. The surgical intervention was carried out endoscopically by diode laser or coblation. The primary endpoint to measure efficacy was drop in apnea-hypopnea index (AHI) on sleep recording at 6 months. Secondary endpoints comprised reduced snoring and Epworth Sleepiness Scale (ESS) and postoperative symptom tolerance. Eleven patients aged 44.3±12.6 years were included. AHI dropped from 29.5±21.7/h to 11.6±9.6/h: i.e., by 60% (P=0.005). Five patients had AHI<10/h: i.e., cure rate of 45%. ESS dropped from 13±3.4 to 8.1±4.9 (P=0.012). No complications were observed. LT ablation seemed effective in OSAS with retrolingual obstruction in failure of medical treatment. 4.
Identifiants
pubmed: 30503688
pii: S1879-7296(18)30190-X
doi: 10.1016/j.anorl.2018.11.001
pii:
doi:
Types de publication
Journal Article
Langues
eng
Pagination
19-23Informations de copyright
Copyright © 2018. Published by Elsevier Masson SAS.